CLINICAL_TRIALS trial_result · 2014-12-01

Clinical Trial Update: Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis [Phase 2]

This Phase 2 trial assessed the safety and efficacy of LEO 80185 Gel for scalp psoriasis in adolescents aged 12 to 17. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: LEO Pharma | Conditions: Scalp Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2014-12-01